Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 602 48 225.9 |
96 | EP file number | EAKZ | 10 17 4985.1 |
97 | EP publication number | EPN | 2269604 |
54 | Designation/title | TI | Behandlung von soliden Nierentumoren mit einem Rapamycin-Derivat |
51 | IPC main class | ICM (ICMV) | A61K 45/06 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/436 (2006.01), A61K 31/337 (2006.01), A61K 31/475 (2006.01), A61K 31/502 (2006.01), A61K 31/555 (2006.01), A61K 31/5685 (2006.01), A61K 31/704 (2006.01), A61K 31/7068 (2006.01), A61P 35/00 (2006.01) |
22 | DE application date | DAT | Feb 18, 2002 |
96 | EP application date | EAT | Feb 18, 2002 |
43 | Date of first publication | OT | Jan 5, 2011 |
| Date of publication of grant | PET | Jul 27, 2016 |
71/73 | Applicant/owner | INH | Novartis Pharma AG, Basel, CH |
72 | Inventor | IN | Lane, Heidi, 4105 Biel-Benken, CH; O'Reilly, Terence, 4057 Basel, CH; Wood, Jeanette Marjorie, 4105 Biel-Benken BL, CH |
| Address for service | | Novartis Pharma AG, 4056 BASEL, CH |
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 0104072 Feb 19, 2001
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 0124957 Oct 17, 2001
|
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 12 2016 000 094.3 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002269604 Searchable text:
EP000002269604 Original document:
EP000002269604B1 Searchable text:
EP000002269604B1 |
43 | Date of first publication | EVT | Jan 5, 2011 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 30, 2022 (Show all update days)(Hide all update days)- Apr 30, 2022; Nov 4, 2021; Feb 12, 2021; Jul 29, 2020; Jun 23, 2020; Feb 14, 2020; Aug 13, 2019; Feb 13, 2019; Sep 20, 2018; Aug 14, 2018; Feb 22, 2018; Jul 6, 2017; Jun 1, 2017; Mar 1, 2017; Sep 8, 2016; Aug 3, 2016; Jul 28, 2016; Jul 14, 2016; May 29, 2015; Feb 15, 2013; Aug 18, 2011
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 9)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jun 23, 2020 |
| Issue number | HN | 31 |
| Year | PJ | 2020 |
| Publication date | VT | Jul 30, 2020 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Novartis Pharma AG, Basel, CH |
71/73 | Previous applicant/owner | INHF | Novartis International Pharmaceutical AG, Basel, CH, Novartis Pharma AG, Basel, CH |
| Date of update of the procedure | REGT | Jul 29, 2020 |